ArticlePharmaceuticals (Basel, Switzerland)2022
Antioxidant and Antibacterial Activity of
Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 38 citations in OpenAlex.
- Nanoencapsulation ofFrontiers in plant science · 2026Article
- Nephroprotective and therapeutic potential of3 Biotech · 2025Article
- Can Provence Flora Offer Effective Alternatives to Widely Used Medicinal Plants? A Comparative Study of Antioxidant Activity and Chemical Composition Using Molecular Networking.Molecules (Basel, Switzerland) · 2025Article
- Combined Herbal Eye Drops Exhibit Neuroprotective and Intraocular Pressure-Reducing Effects in a Glaucoma Rat Model.Antioxidants (Basel, Switzerland) · 2025Article
- A Comparative Phytochemical Investigation of the Greek Members of the GenusPlants (Basel, Switzerland) · 2025Article
- Advances in plant essential oils and drug delivery systems for skincare.Frontiers in pharmacology · 2025Review
- Immortelle Essential-Oil-Enriched Hydrogel for Diabetic Wound Repair: Development, Characterization, and In Vivo Efficacy Assessment.Pharmaceutics · 2024Article
- Antibacterial and Antifungal Potential ofAntibiotics (Basel, Switzerland) · 2024Review
- Combination of Chromatographic Analysis and Chemometric Methods with Bioactivity Evaluation of the Antibacterial Properties ofAntibiotics (Basel, Switzerland) · 2024Article
- Novel Antibacterial Agents 2022.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Electrospun Nanofibers Encapsulated with Natural Products: A Novel Strategy to Counteract Skin Aging.International journal of molecular sciences · 2024Article
- HPLC Analysis and In Vitro and In Silico Evaluation of the Biological Activity of Polyphenolic Components Separated with Solvents of Various Polarities fromMolecules (Basel, Switzerland) · 2023Article
- Phytochemical Profiling, Antioxidant and Cognitive-Enhancing Effect ofPlants (Basel, Switzerland) · 2023Article
- Chemical Profiling and Bioactivity Assessment ofMolecules (Basel, Switzerland) · 2023Article
- Hydroxypropyl-β-Cyclodextrin-BasedAntioxidants (Basel, Switzerland) · 2023Article
- Review
- Optimization of Cyclodextrin-Assisted Extraction of Phenolics fromMetabolites · 2023Article
- Potential of Aromatic Plant-Derived Essential Oils for the Control of Foodborne Bacteria and Antibiotic Resistance in Animal Production: A Review.Antibiotics (Basel, Switzerland) · 2022Review
- Green Synthesis of Gold Nanoflowers UsingAntibiotics (Basel, Switzerland) · 2022Article
- Antioxidant and Antimicrobial Properties ofAntibiotics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.